Inspur Helped Chongqing Drug Smart Supervision Platform To Be Awarded "2021 Smart Regulatory Typical Cases"

Chongqing, November 1, 2021 / PRNewswire/ -- On September 27-28, the 2021 Pharmaceutical Digital Intelligence Development Conference hosted by the Information Center of the State Drug Administration (China Food and Drug Administration Data Center) was held in Hefei. With the theme of "Data Service Development, Innovation and Wisdom Leading the Future", the conference talked about the digital and intelligent development trend of the pharmaceutical industry in the new era, accelerated the transformation and upgrading of regulatory methods, and promoted the high-quality development of the pharmaceutical industry. At the meeting, the list of typical cases of smart supervision of drugs in 2021 was announced, and the Chongqing smart supervision platform built by Inspur was awarded the "Typical Cases of Smart Supervision in 2021".

In this selection activity, the Food and Drug Administration of various provinces (municipalities and districts) across the country recommended a total of 80 excellent cases of wisdom supervision and smart joint governance to participate in the selection, and after online display voting and expert review, 19 typical cases of smart supervision were finally evaluated, and 4 typical cases of smart joint governance in Chongqing Were successfully awarded the "2021 Smart Supervision Typical Cases" after layers of selection.

Under the guidance of Chongqing Municipal Drug Administration, the Chongqing Drug Intelligent Supervision Platform, built by Inspur Software, is built in accordance with the overall idea of "big platform, big data, and big system", realizing the integration and integration of various business application systems, as well as the unified authentication, unified user login and management of new and old business systems, establishing an approval and supervision linkage mechanism, realizing information sharing and business coordination of systems such as review and inspection, license approval, daily supervision, and administrative law enforcement, and strengthening supervision before and after the event. Deeply promote the unified construction of the "two products and one device" license approval system for the whole life cycle of drugs, carry out the "one network communication office", realize the application of big data by letting the people run more data and run less errands, strengthen data classification analysis and display, give full play to the value of data, and provide accurate services for high-quality supervision.

Yan Jiangying, deputy director of the State Drug Administration, attaches great importance to the drug supervision system and capacity building, and insists on leading the modernization of supervision with informatization Yan Jiangying, deputy director of the State Drug Administration, said in her opening speech that it is necessary to build information means into the "clairvoyance and tailwind ear" of the regulatory departments, and use information technology to serve the development of the industry.

Shang Liang, general manager of the market supervision and product department of the Inspur Software Government Informatization Division, said in his speech that in the new era, the drug regulatory industry will exert efforts in the following four aspects: the organic integration of supervision at all stages of the drug life cycle with varieties as the core establishes a mechanism for communication with supervision and service objects, standardizes and serves at the same time, promotes information interaction to establish drug life cycle archives, and comprehensively integrates variety data, regulatory information and knowledge base to cultivate a multi-functional composite full-time inspection team.

Under the framework of the State Council's implementation opinions on comprehensively strengthening drug regulatory capacity building, and guided by the Action Plan of the State Drug Administration on accelerating the promotion of smart drug supervision, Inspur has constructed the integrated application of "smart drug supervision", initially formed an innovative development pattern of smart supervision with "large platform support, big data wisdom governance, large system integration, large service to benefit the people, and large supervision and co-governance", and promoted the deep integration of information technology and regulatory work.

Since 2003, Inspur has undertaken the construction of quality supervision business, in 2007 to undertake the construction of industry and commerce, food and drug business, service market supervision field informatization construction has been 18 years, during which Inspur has served more than 100 various types of market supervision and informatization projects at all levels, has a number of software copyrights and patents in the market supervision industry, the market share ranks in the forefront of the country, set up an industry benchmarking demonstration role, laid a leading position in the market supervision information industry.

At present, Inspur focuses on creating smart market supervision informatization solutions, based on the "14th Five-Year Plan" market supervision work, closely following the overall requirements of the state administration of market supervision informatization construction technology program, focusing on the construction of a unified and open, orderly competition, integrity and law-abiding, strong supervision of the modern market system system, the construction of a unified market supervision informatization system mechanism, and gradually form a market supervision informatization innovation and development pattern, to help achieve the "smart market supervision" wave will continue to focus on the new trend of smart regulatory development in the new era. It will help the regulatory transformation of smart drugs and the high-quality development of the pharmaceutical industry with new technologies such as smart computing, data governance, and artificial intelligence.